Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/26240
Title: Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis.
Authors: 
Keywords: 
Issue Date: Jun-2016
Citation: Clin Kidney J.2016 Jun;(9)3:381-6
Abstract: Variability in the management of glomerulonephritis may negatively impact efficacy and safety. However, there are little/no data on actual variability in the treatment of minimal change disease (MCD)/focal segmental glomerulosclerosis (FSGS) in adults. We assessed Spanish practice patterns for the management of adult nephrotic syndrome due to MCD or FSGS. The absence of reasonably good evidence on treatment for a disease often increases the variability substantially. Identification of evidence-practice gaps is the first necessary step in the knowledge-to-action cyclical process. We aim to analyse the real clinical practice in adults in hospitals in Spain and compare this with the recently released Kidney Disease: Improving Global Outcomes clinical practice guideline for glomerulonephritis.
PMID: 27274821
URI: https://hdl.handle.net/20.500.12530/26240
Rights: openAccess
ISSN: 2048-8505
Appears in Collections:Hospitales > H. U. Fundación Alcorcón > Artículos
Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos
Hospitales > H. U. La Paz > Artículos
Fundaciones e Institutos de Investigación > FIB H. U. Príncipe de Asturias > Artículos

Files in This Item:
File Description SizeFormat 
PMC4886920.pdf433.59 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.